The NCI Community Oncology Research Program (NCORP) is a national network of cancer care investigators, providers, academia, and other organizations that care for diverse populations in health systems.
The DCP Community Oncology and Prevention Trials Research Group administers this program.
On This Page
- All Heading 2s will automatically be pulled in to this list.
- Do not edit the content on this template.
About NCORP
The program brings cancer clinical trials and control and delivery studies to individuals in their own communities, thereby generating a broadly applicable evidence base that contributes to improved patient outcomes and a reduction in cancer disparities.
Grantee Details
No matching Grants were found.
Clinical Trials
| Title Sort descending | Intervention | Sponsor | Status |
|---|---|---|---|
| A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources | Internet-Based Intervention - CONNECT, Patient Navigation, Support for Caregiver - Generic List, Support for Caregiver - Personalized List | Wake Forest University Health Sciences | Enrolling by invitation |
| Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts | Contrast-enhanced Magnetic Resonance Imaging, Digital Tomosynthesis Mammography, Quality-of-Life Assessment, Questionnaire Administration | ECOG-ACRIN Cancer Research Group | Active, not recruiting |
| Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy | Placebo Acupressure Band, Real Acupressure Band | University of South Florida | Completed |
| Acute Pain Caused by Paclitaxel in Patients With Cancer | pain questionnaires | Alliance for Clinical Trials in Oncology | Completed |
| Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy | Best Practice, Educational Intervention, Motivational Interviewing, Quality-of-Life Assessment, Questionnaire Administration, Text Message-based Navigation Intervention | Alliance for Clinical Trials in Oncology | Active, not recruiting |
| An Internet-based Program to Help Cancer Survivors Manage Pain | Internet-based pain coping skills program | Wake Forest University Health Sciences | Recruiting |
| An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study | Biospecimen Collection, Electronic Health Record Review, Interview, Quality-of-Life Assessment, Questionnaire Administration | University of Rochester NCORP Research Base | Recruiting |
| An Observational Research Study to Uncover Subtypes of Cancer Cachexia | Biospecimen Collection, Computed Tomography, Electronic Medical Record, Medical Device Usage and Evaluation, Physical Performance Testing, Positron Emission Tomography, Survey Administration | University of Rochester NCORP Research Base | Recruiting |
| An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer | Dasatinib plus Quercetin, Fisetin | St. Jude Children's Research Hospital | Active, not recruiting |
| Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy | Antiemetic treatment (ondansetron or granisetron or palonosetron; plus dexamethasone; plus fosaprepitant or aprepitant), Chemotherapy (cisplatin or cyclophosphamide and doxorubicin), Olanzapine, Placebo | Alliance for Clinical Trials in Oncology | Completed |
News and Events
NCORP recognizes Judith Hopkins, Kristina Gardner, and Marge Good with 2024 awards
Date Posted: September 26, 2024
AACR Announces 2024 Distinguished Public Service Award Recipients
Date Posted: February 19, 2024
Following Abnormal Cancer Screening Results, Multi-Level Reminders May Increase Follow-Up
Date Posted: December 22, 2023
Worta McCaskill-Stevens, M.D.: An Appreciation for a Driving Force in Cancer Prevention and Addressing Cancer Disparities
Date Posted: November 17, 2023
Acting Chief of Community Oncology and Prevention Trials Research Group Named
Date Posted: November 1, 2023